Publicacións en colaboración con investigadores/as de Universidad de La Laguna (49)

2024

  1. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

    Antioxidants, Vol. 13, Núm. 10

  2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  3. Early identification of golimumab-treated patients with higher likelihood of long-term retention

    Frontiers in Immunology, Vol. 15

  4. Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 8, pp. 1564-1570

  5. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  6. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

    Life, Vol. 14, Núm. 4

  7. Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780

  8. Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis

    Frontiers in Immunology, Vol. 15

  9. Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 12, Núm. 5

  10. The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 26, Núm. 1

  11. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2023

  1. Alpha-Klotho protein in systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 41-47

  2. Blood Composite Scores in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 11, Núm. 10

  3. Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis

    Life, Vol. 13, Núm. 1

  4. Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III

    Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 67-73

  5. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

  6. Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases

    Advances in Rheumatology, Vol. 63, Núm. 1

  7. Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

  8. HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  9. Hematological Composite Scores in Patients with Inflammatory Bowel Disease

    Journal of Clinical Medicine, Vol. 12, Núm. 23